{"title":"Pyridazine (1,2-Diazine): A Versatile Pharmacophore Known for its Utility in Biological Systems","authors":"Swati Sharma","doi":"10.2174/0115734072271233231113070640","DOIUrl":null,"url":null,"abstract":"\n\nThe present review describes the biological essence of pyridazine scaffold. Around\n142 biologically potential pyridazine entities are gathered in a pile from documented literature.\nSome of them are commercially available drugs, few are naturally occurring pyridazine compounds,\nand a wide variety of compounds containing pyridazine moiety are biologically tested,\nand some are under clinical trials. Rather than collecting large quantities of data, an attempt is\nmade to compile valuable entities. However, efforts have been made to compile the maximum\nliterature in brief. The main motto of this review is to provide a combination of therapeutically\nactive pyridazine containing compounds for further drug design, discovery, and development to\ncontribute to future medicinal chemistry. Our approach is to bring the most biologically potent\npyridazine derivatives to medicinal chemists, biologists, pharmacists, and organic chemists. The\npresent work encompasses the literature from 2000-2022 from different and authentic sources.\nThe work is divided according to the bioactive nature of pyridazine nucleus.\n","PeriodicalId":10772,"journal":{"name":"Current Bioactive Compounds","volume":"63 11","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Bioactive Compounds","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/0115734072271233231113070640","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0
Abstract
The present review describes the biological essence of pyridazine scaffold. Around
142 biologically potential pyridazine entities are gathered in a pile from documented literature.
Some of them are commercially available drugs, few are naturally occurring pyridazine compounds,
and a wide variety of compounds containing pyridazine moiety are biologically tested,
and some are under clinical trials. Rather than collecting large quantities of data, an attempt is
made to compile valuable entities. However, efforts have been made to compile the maximum
literature in brief. The main motto of this review is to provide a combination of therapeutically
active pyridazine containing compounds for further drug design, discovery, and development to
contribute to future medicinal chemistry. Our approach is to bring the most biologically potent
pyridazine derivatives to medicinal chemists, biologists, pharmacists, and organic chemists. The
present work encompasses the literature from 2000-2022 from different and authentic sources.
The work is divided according to the bioactive nature of pyridazine nucleus.
Current Bioactive CompoundsPharmacology, Toxicology and Pharmaceutics-Pharmacology, Toxicology and Pharmaceutics (all)
CiteScore
1.90
自引率
0.00%
发文量
112
期刊介绍:
The journal aims to provide comprehensive review articles on new bioactive compounds with proven activities in various biological screenings and pharmacological models with a special emphasis on stereoeselective synthesis. The aim is to provide a valuable information source of bioactive compounds synthesized or isolated, which can be used for further development of pharmaceuticals by industry and academia. The journal should prove to be essential reading for pharmacologists, natural product chemists and medicinal chemists who wish to be kept informed and up-to-date with the most important developments on new bioactive compounds of natural or synthetic origin, including their stereoeselective synthesis.